The escherichia coli project passed the approval meaning the local government expert institutions fully affirmed for our company's research and development capabilities and achievements in recent years.in the future, we will increase our innovation and make the technology center becoming a research platform for new products and new technologies. We will become a platform for attracting and pooling scientific and technological talents, mobilizing and developing its enthusiasm and creativity. To strengthen cooperation in production and research, in accordance with the "Benefit sharing, risk sharing" Principle for development of new products and new technologies, the establishment of research institutes and laboratories, co-training of technical personnel will provide our customers with better service and help.
Ciprofloxacin is a broad-spectrum antibiotic that is active against Crampositive.Gram-negative bacteria, Myco plasma infection, Ecoli, Salmonella, Anaerobic bacterobic infection and Streptocossus, etc.
It is used for treatment of bacterial infection and Myco plasma infection in livestock and Poultry.
and also used for gastrointestinal, respiratory and urinary tract infections caused by ciprofloxacin sensitive micro-organisms like Campylobacter, E. coli,Haemophilus, Mycoplasma, Pasteurella and Salmonella spp. in calves, goats, poultry, sheep and swine.
Ciprofloxacin
Ciprofloxacin Injection,Ciprofloxacin Solution,Ciprofloxacin Oral Solution,Antibiotic Ciprofloxacin
Hebei Kexing Pharmaceutical Co., Ltd. , https://www.kexingpharma.com
没有评论:
发表评论